<DOC>
	<DOCNO>NCT00138060</DOCNO>
	<brief_summary>This study intend optimize fluorouracil/irinotecan chemotherapy regimen identification individual thymidylate synthase ( TS ) UDP-glucuronosyltransferase 1 ( UGT1A1 ) polymorphisms first administration . The result identification determine chemotherapy type : high-dose irinotecan .</brief_summary>
	<brief_title>Toxicity/Benefit Ratio Optimization Chemotherapy Colorectal Cancer ( CRC ) Patients Determination Individual Genotypic Determinants</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Has provide write informed consent prior studyspecific screening procedure , understand patient right withdraw study time without prejudice Ages 18 85 year Histologically confirm colorectal cancer No treatment metastatic disease No irinotecan previously administer World Health Organization ( WHO ) performance status &lt; 3 Laboratory value : neutrophil &gt; 1.5 x 10^9/L ; platelet count &gt; 100 x 10^9/L ; serum creatinine &lt; 130Âµmol/L ; serum bilirubin &lt; 2 x upper limit normal ( ULN ) ; ASAT ALAT &lt; 2.5 x ULN ; alkaline phosphatase &lt; 5 x ULN . At least one measurable lesion Response Evaluation Criteria Solid Tumors ( RECIST ) criteria History another malignancy except cure basal cell carcinoma skin carcinoma situ uterine cervix , breast bladder . Other concomitant anticancer therapy . Pregnant lactating woman . Women childbearing potential unless use reliable appropriate contraceptive method . Symptomatic cerebral leptospiral metastasis . Intestinal obstruction . Uncontrolled seizure ( diabetes , severe infection ) . Clinically significant cardiac disease . Central nervous system disorder severe psychiatric disability . Participation investigational study within 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>genotypic profile</keyword>
	<keyword>metastatic colorectal cancer</keyword>
</DOC>